Femasys Inc. Announces Appointment of New Board Member
ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today announced the appointment of Anne Morrissey to the companys board of directors.
- ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today announced the appointment of Anne Morrissey to the companys board of directors.
- Anne is an accomplished industry veteran with an impressive track record of leading innovative healthcare companies, and we are delighted to welcome her to our board, said Kathy Lee-Sepsick, founder, President & Chief Executive Officer of Femasys.
- Femasys has made remarkable progress with its portfolio of female focused products, said Ms. Morrissey.
- Femasys has also developed a novel technology platform for tissuesampling intended to be marketed alongside our other women-specific medical products in the physicians officesetting.